Effects of Mental Health Disorders on Pain Monitoring and Treatment in VA CLCs
Effects of Mental Health Disorders on Pain Monitoring and Treatment in VA CLCs
批准号:
8398810
负责人:
Penny Brennan
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-03-01 至 2016-02-29
关键词:
AffectAgeAnalgesicsArthritisBehavioralCLC GeneCardiovascular DiseasesCharacteristicsClinicalCognitiveCommunitiesCross-Sectional StudiesDataData AnalysesData SetDatabasesDementiaDepressive disorderDiabetes MellitusEducationElderlyGuidelinesHealthHealthcareHealthcare SystemsInterventionInterviewKnowledgeLinkLong-Term CareMediatingMedicalMental DepressionMental disordersMonitorMoodsNursing HomesOutcomePainPain managementPatient CarePatient Self-ReportPatientsPharmacy facilityPrevalenceRecommendationRegimenResearchSamplingScheduleSubstance Use DisorderSurveysTimeTreatment outcomeValidity and ReliabilityVulnerable Populationsclinically significantcohortcommunity livingdepressive symptomseffective therapyexperiencehandbookimprovedinstrumentmusculoskeletal disorder diagnosispatient populationprospectivesevere mental illness
中文摘要
描述(由申请人提供):
本项目的目的是使用纵向最小数据集(MDS 3.0)居民评估数据,以确定老年人的心理健康障碍,特别是他们的抑郁症和临床显著抑郁症,对他们作为VA社区生活中心(VA CLC)居民接受疼痛治疗的类型和结果的影响。有效的疼痛治疗是整个VA医疗保健系统的关键目标,特别是在VA CLC中。CLC居民是一个弱势群体,他们的健康和功能特点限制了他们成功启动和持续努力,以获得有效治疗继承人疼痛的能力。有提示性证据表明,精神健康障碍,包括抑郁症和临床显著抑郁症,进一步阻碍VA CLC居民获得有效的疼痛治疗。然而,大多数证据是轶事或已在年轻和混合年龄患者人群的横断面研究中获得。来自新升级的最小数据集居民评估工具(MDS 3.0)的纵向数据提供了一个独特的机会,以促进了解老年人心理健康障碍对他们在VA CLC中接受疼痛治疗的类型和结果的影响。MDS评估调查首次包括疼痛治疗项目和通过居民自我报告获得的一组扩展的疼痛项目。VA CLC居民每3个月进行一次MDS 3.0评估;这些居民水平数据的跨时间链接允许对VA CLC居民中心理健康障碍、疼痛治疗和疼痛治疗结果之间的关系进行前瞻性和其他纵向分析。我们将对从诊断为肌肉骨骼疾病的老年VA CLC居民队列中获得的纵向MDS数据进行二次数据分析,以实现这些特定目标:(a)确定老年人的心理健康障碍,特别是抑郁症对疼痛治疗的短期影响,以及疼痛治疗结果,他们作为VA CLC居民的经验;(B)确定四种特定MDS评估的疼痛治疗建议是否在患有精神健康障碍,特别是抑郁障碍与较差的短期疼痛治疗结果之间起中介作用;以及(c)确定老年人的基线精神健康障碍,特别是抑郁症,影响随后12个月的疼痛治疗结果,以及这些12个月疼痛治疗结果轨迹与居民12个月身体、认知和行为功能轨迹的关系。
英文摘要
DESCRIPTION (provided by applicant):
The purpose of this project is to use longitudinal Minimum Dataset (MDS 3.0) resident assessment data to determine the influence of older adults' mental health disorders, especially their depressive disorders and clinically significant depression, on the types and outcomes of pain treatment they receive as residents in VA Community Living Centers (VA CLCs). Effective pain treatment is a key objective throughout the VA health care system, but particularly in VA CLCs. CLC residents are a vulnerable population whose health and functioning characteristics limit their ability to successfully initiate and sustain efforts to obtain effective treatment for heir pain. There is suggestive evidence that mental health disorders, including depressive disorders and clinically significant depression, further impede VA CLC residents' access to effective pain treatment. However, most of this evidence is anecdotal or has been obtained in cross-sectional studies of younger and mixed-age patient populations. Longitudinal data from the newly upgraded Minimum Dataset resident assessment instrument (MDS 3.0) provide a unique opportunity to advance knowledge about the influence of older adults' mental health disorders on the types and outcomes of pain treatment they receive in VA CLCs. For the first time, the MDS assessment survey includes pain treatment items, and an expanded set of pain items, obtained through resident self-report. VA CLC residents are assessed with MDS 3.0 every 3 months; cross-temporal linking of these resident-level data permit prospective and other longitudinal analyses of relationships among mental health disorders, pain treatment, and pain treatment outcomes among VA CLC residents. We will conduct secondary data analyses of longitudinal MDS data obtained from a cohort of older VA CLC residents with diagnosed musculoskeletal disorders in order to achieve these specific aims: (a) to determine the short- term influence of older adults' mental health disorders, particularly depressive disorders, on the pain treatments, and pain treatment outcomes, they experience as VA CLC residents; (b) determine whether four specific MDS-assessed pain treatment recommendations mediate between having a mental health disorder, particularly depressive disorders, and poorer short- term pain treatment outcomes; and (c) ascertain how older adults' baseline mental health disorders, particularly depressive disorders, affect the subsequent 12-month course of their pain treatment outcomes, and the relationship of these 12-month pain treatment outcome trajectories to residents' 12-month physical, cognitive, and behavioral functioning trajectories.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Successful Implementation of Consistent Staff Assignment in VA CLCs
-
批准号:8729712
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Penny Brennan
-
依托单位:
Pain, Depression and Alcohol Use in Later Life
-
批准号:7821442
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2009
-
负责人:Penny Brennan
-
依托单位:
Pain, Depression and Alcohol Use in Later Life
-
批准号:7663330
-
项目类别:
-
资助金额:$17.01万
-
财政年份:2009
-
负责人:Penny Brennan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: